Adamas: 4Q Earnings Snapshot

EMERYVILLE, Calif. (AP) _ Adamas Pharmaceuticals Inc. (ADMS) on Tuesday reported a loss of $18.3 million in its fourth quarter.

The Emeryville, California-based company said it had a loss of 64 cents per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 53 cents per share.

The drugmaker posted revenue of $21 million in the period, which topped Street forecasts. Four analysts surveyed by Zacks expected $20.8 million.

For the year, the company reported that its loss narrowed to $57.4 million, or $2.03 per share. Revenue was reported as $74.5 million.

Adamas shares have increased 19% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $5.14, a fall of 2% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ADMS at